Samuel D. Waksal
CHF 49.20
Auf Lager
SKU
BN7OB6N6445
1 Verfügbar
Geliefert zwischen Mi., 24.09.2025 und Do., 25.09.2025
Details
High Quality Content by WIKIPEDIA articles! Samuel D. Waksal is the founder and former CEO of the biopharmaceutical company ImClone Systems, which developed the drug Erbitux . In the course of an insider trading scandal, he was convicted of several white collar crimes, served time in federal prison, and has now been released. Waksal earned a bachelor's degree in 1969 and a doctorate in immunobiology in 1974, both from The Ohio State University. He was arrested June 12, 2002 on insider trading charges. On October 15, he pleaded guilty to charges of securities fraud, bank fraud, obstruction of justice, and perjury. On March 3, 2003 he pleaded guilty to charges of conspiracy and wire fraud for avoiding $1.2 million in sales taxes on $15 million in artwork. The art included works by Mark Rothko, Richard Serra, Roy Lichtenstein, and Willem de Kooning, purchased between June 2000 and October 2001. He did not pay the necessary taxes at the time of purchase, but did pay the taxes in fall 2002.
30 Tage Rückgaberecht
GarantieWeitere Informationen
- Allgemeine Informationen
- Editor Lambert M. Surhone, Miriam T. Timpledon, Susan F. Marseken
- Titel Samuel D. Waksal
- Format Fachbuch
- EAN 9786130446512
- Genre Medizin
- Anzahl Seiten 120
- Herausgeber Betascript Publishing
- GTIN 09786130446512
Bewertungen
Schreiben Sie eine Bewertung
